Translating Genetic Biomarkers to the Clinic: The Promise and Pitfalls of Developing Robust, Reliable Signatures
The recent Affymetrix sponsored Science/AAAS webinar entitled “Translating Genetic Biomarkers to the Clinic: The Promise and Pitfalls of Developing Robust, Reliable Signatures” [view webinar], highlighted some very interesting aspects of translating biomarker research into products that are ready for clinical use. The Q&A session that ensued included many [...]
Translational sciences: Shouldn’t we go beyond genomics?
Cancer is one of the most characteristic examples of a disease for which the scientific community has come together to systematically produce vast amounts of genomic data. The aim is to gain a better understanding of this disease in order to create targeted therapeutic compounds and companion diagnostics, and improve cancer [...]
Genomics, transcriptomics, proteomics – is it time for validomics?
Today we celebrate DNA day, which commemorates the publication of the structure of DNA in 1953¹. On this very day in 2003, the Human Genome Project (HGP) was completed, providing us with a reference sequence of the human genome². The draft sequence had been provided two years earlier, in 2001³,⁴. Since the [...]
About the Author
Recent Posts
- Top 6 trends in translational science in 2012
- Translating Genetic Biomarkers to the Clinic: The Promise and Pitfalls of Developing Robust, Reliable Signatures
- Is the medical community ready to interpret these new molecular vital signs in their medical bag?
- Digging into the archives – unlocking the full potential of tumor samples
- Genome-wide association studies: which method to choose?
